• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

iSpecimen Launches First Online Marketplace for Human Biospecimens

by Fred Pennic 06/15/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

iSpecimen Launches First Online Marketplace for Human Biospecimens

 iSpecimen, a Lexington, MA-based startup has launched the iSpecimen Marketplace, an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges – how to compliantly obtain quality biospecimens in a cost-effective manner. Through the marketplace, researchers gain instant access to iSpecimen’s growing, federated network of healthcare providers and biobanks, giving network participants (specimen providers) the opportunity to more broadly contribute to medical research as well as their bottom line.

In this age of precision medicine, biomedical research is booming. Traditionally, obtaining the biospecimens required for R&D has been time-consuming and expensive. Researchers often do the legwork themselves, approaching a fragmented network of biobanks, clinical laboratories, and specimen brokers to cobble together collections. More often than not, this process fails to result in the quality or quantity of specimens needed. Researchers lose precious time as they search, and repeatedly don’t find what they need. In fact, according to one National Cancer Institute study, four out of five researchers reported limiting the scope of their work due to inadequate supply of high-quality biospecimens.

The iSpecimen Marketplace solves this problem by using proprietary technology to bridge the gap between researchers and specimens. Accessing de-identified electronic medical record and laboratory data from across a network of participating partner organizations – including hospitals, labs, biobanks, blood centers and other healthcare institutions – iSpecimen’s technology aggregates a vast amount of information about individual specimens and the patients from whom they came into a single, harmonized view. Researchers can quickly and easily search this data using detailed patient, specimen, and compliance criteria and instantly view the availability and details of specimens that meet their specific needs. Contracting is likewise simplified and accelerated, as researchers and providers alike contract once with iSpecimenand gain access to all other organizations in the network. 

Additional features of the iSpecimen Marketplace include automated fulfillment and procurement processes, offering a partner-facing web interface that directs specimen selection, packing, and shipping. Further, as a benefit of participation,iSpecimen partners can use the technology to gain insight into their own specimen availability as well as access specimens from across the network for their own internal research needs.

“A diverse and ready supply of biospecimens is critical to accelerating research,” said Christopher Ianelli, MD, PhD, Founder and Chief Executive Officer, iSpecimen. “New diagnostics and treatments will only be as precise as the research work behind it. Our job is to close the gap between the research and provider communities by matching highly refined specimen requests to organizations that can fulfill them. We’re like a Kayak.com for biospecimen research, making sure these critical connections are made.”

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Human Biospecimens, iSpecimen

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |